Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Commonwealth Biotechnologies, Inc. CBI
Commonwealth Biotechnologies, Inc. Receives Marketplace Rule 4310c3 and Going Concern Notices
May 2nd, 2009
Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market:CBTE), a life sciences contract research organization and biotechnology company, announced that a Going Concern qualification has been added by its independent auditor's report for fiscal year 2008 which was filed with the Company's Annual Report and Form 10-K on March 31, 2009. In addition, the company was notified on April 8, 2009 that as of December 31, 2008 it was out of compliance with NASDAQ Marketplace Rule 4310(c)(3) which requires a minimum stockholders' equity of $2,500,000, $35 million market capitalization, or $500,000 of net income from continuing operations for the most recently completed...
Source: Law & Health Weekly (2009-05-02)
|
